• Türkçe
    • English
  • English 
    • Türkçe
    • English
  • Login
View Item 
  •   DSpace@İSÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed | DergiPark
  • PubMed İndeksli Yayınlar Koleksiyonu
  • View Item
  •   DSpace@İSÜ
  • Araştırma Çıktıları | TR-Dizin | WoS | Scopus | PubMed | DergiPark
  • PubMed İndeksli Yayınlar Koleksiyonu
  • View Item
JavaScript is disabled for your browser. Some features of this site may not work without it.

Comprehensive tumor molecular profle analysis in clinical practice

Thumbnail

View/Open

Tam Metin/Full Text (2.922Mb)

Date

2021

Author

Ozdogan, Mustafa
Papadopoulou, Eirini
Tsoulos, Nikolaos
Tsantikidi, Aikaterini
Mariatou, Vasiliki‑Metaxa
Cakir, Okan

Metadata

Show full item record

Citation

Özdoğan, M., Papadopoulou, E., Tsoulos, N., Tsantikidi, A., Mariatou, V. M., Tsaousis, G., Kapeni, E., Bourkoula, E., Fotiou, D., Kapetsis, G., Boukovinas, I., Touroutoglou, N., Fassas, A., Adamidis, A., Kosmidis, P., Trafalis, D., Galani, E., Lypas, G., Orhan, B., Tansan, S., … Nasioulas, G. (2021). Comprehensive tumor molecular profile analysis in clinical practice. BMC medical genomics, 14(1), 105. https://doi.org/10.1186/s12920-021-00952-9

Abstract

Background: Tumor molecular profle analysis by Next Generation Sequencing technology is currently widely applied in clinical practice and has enabled the detection of predictive biomarkers of response to targeted treatment. In parallel with targeted therapies, immunotherapies are also evolving, revolutionizing cancer therapy, with Pro‑ grammed Death-ligand 1 (PD-L1), Microsatellite instability (MSI), and Tumor Mutational Burden (TMB) analysis being the biomarkers employed most commonly. Methods: In the present study, tumor molecular profle analysis was performed using a 161 gene NGS panel, containing the majority of clinically signifcant genes for cancer treatment selection. A variety of tumor types have been analyzed, including aggressive and hard to treat cancers such as pancreatic cancer. Besides, the clinical utility of immunotherapy biomarkers (TMB, MSI, PD-L1), was also studied. Results: Molecular profle analysis was conducted in 610 cancer patients, while in 393 of them a at least one bio‑ marker for immunotherapy response was requested. An actionable alteration was detected in 77.87% of the patients. 54.75% of them received information related to on-label or of-label treatment (Tiers 1A.1, 1A.2, 2B, and 2C.1) and 21.31% received a variant that could be used for clinical trial inclusion. The addition to immunotherapy biomarker to targeted biomarkers’ analysis in 191 cases increased the number of patients with an on-label treatment recommenda‑ tion by 22.92%, while an option for on-label or of-label treatment was provided in 71.35% of the cases. Conclusions: Tumor molecular profle analysis using NGS is a frst-tier method for a variety of tumor types and provides important information for decision making in the treatment of cancer patients. Importantly, simultaneous analysis for targeted therapy and immunotherapy biomarkers could lead to better tumor characterization and ofer actionable information in the majority of patients. Furthermore, our data suggest that one in two patients may be eli‑ gible for on-label ICI treatment based on biomarker analysis. However, appropriate interpretation of results from such analysis is essential for implementation in clinical practice and accurate refnement of treatment strategy.

Source

BMC Medical Genomics

Volume

14

Issue

105

URI

https://doi.org/10.1186/s12920-021-00952-9
https://hdl.handle.net/20.500.12713/1696

Collections

  • PubMed İndeksli Yayınlar Koleksiyonu [1153]
  • Scopus İndeksli Yayınlar Koleksiyonu [1892]
  • Tıbbi Görüntüleme Teknikleri Programı Makale Koleksiyonu [6]
  • WoS İndeksli Yayınlar Koleksiyonu [1965]



DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 




| Instruction | Guide | Contact |

DSpace@İSÜ

by OpenAIRE
Advanced Search

sherpa/romeo

Browse

All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution AuthorThis CollectionBy Issue DateAuthorsTitlesSubjectsTypeLanguageDepartmentCategoryPublisherAccess TypeInstitution Author

My Account

LoginRegister

Statistics

View Google Analytics Statistics

DSpace software copyright © 2002-2015  DuraSpace
Contact Us | Send Feedback
Theme by 
@mire NV
 

 


|| Guide|| Instruction || Library || İstinye University || OAI-PMH ||

İstinye University, İstanbul, Turkey
If you find any errors in content, please contact:

Creative Commons License
İstinye University Institutional Repository is licensed under a Creative Commons Attribution-NonCommercial-NoDerivs 4.0 Unported License..

DSpace@İSÜ:


DSpace 6.2

tarafından İdeal DSpace hizmetleri çerçevesinde özelleştirilerek kurulmuştur.